Literature DB >> 24217770

Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels.

Xavier F Figueroa1, Daniel R González, Mariela Puebla, Juan P Acevedo, Daniel Rojas-Libano, Walter N Durán, Mauricio P Boric.   

Abstract

BACKGROUND/AIMS: Endothelial nitric oxide synthase (eNOS) is associated with caveolin-1 (Cav-1) in plasma membrane. We tested the hypothesis that eNOS activation by shear stress in resistance vessels depends on synchronized phosphorylation, dissociation from Cav-1 and translocation of the membrane-bound enzyme to Golgi and cytosol.
METHODS: In isolated, perfused rat arterial mesenteric beds, we evaluated the effect of changes in flow rate (2-10 ml/min) on nitric oxide (NO) production, eNOS phosphorylation at serine 1177, eNOS subcellular distribution and co-immunoprecipitation with Cav-1, in the presence or absence of extracellular Ca(2+).
RESULTS: Increases in flow induced a biphasic rise in NO production: a rapid transient phase (3-5-min) that peaked during the first 15 s, followed by a sustained phase, which lasted until the end of stimulation. Concomitantly, flow caused a rapid translocation of eNOS from the microsomal compartment to the cytosol and Golgi, paralleled by an increase in eNOS phosphorylation and a reduction in eNOS-Cav-1 association. Transient NO production, eNOS translocation and dissociation from Cav-1 depended on extracellular Ca(2+), while sustained NO production was abolished by the PI3K-Akt blocker wortmannin.
CONCLUSIONS: In intact resistance vessels, changes in flow induce NO production by transient Ca(2+)-dependent eNOS translocation from membrane to intracellular compartments and sustained Ca(2+)-independent PI3K-Akt-mediated phosphorylation.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217770      PMCID: PMC3910107          DOI: 10.1159/000355301

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  57 in total

1.  EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries.

Authors:  U Pohl; K Herlan; A Huang; E Bassenge
Journal:  Am J Physiol       Date:  1991-12

2.  Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels.

Authors:  L Kuo; W M Chilian; M J Davis
Journal:  Am J Physiol       Date:  1991-12

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

4.  Endothelium regulates skeletal muscle microcirculation by a blood flow velocity-sensing mechanism.

Authors:  A Koller; G Kaley
Journal:  Am J Physiol       Date:  1990-03

5.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

6.  Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.

Authors:  J P Cooke; E Rossitch; N A Andon; J Loscalzo; V J Dzau
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization.

Authors:  L Busconi; T Michel
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

8.  Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs.

Authors:  A Chu; D E Chambers; C C Lin; W D Kuehl; F R Cobb
Journal:  Am J Physiol       Date:  1990-04

9.  Role of endothelium-derived nitric oxide in the regulation of blood pressure.

Authors:  D D Rees; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor.

Authors:  T Malinski; Z Taha
Journal:  Nature       Date:  1992-08-20       Impact factor: 49.962

View more
  13 in total

1.  Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6.

Authors:  Vanessa Cavieres; Karla Valdes; Brayan Moreno; Rodrigo Moore-Carrasco; Daniel R Gonzalez
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

2.  Exercise training improves vascular mitochondrial function.

Authors:  Song-Young Park; Matthew J Rossman; Jayson R Gifford; Leena P Bharath; Johann Bauersachs; Russell S Richardson; E Dale Abel; J David Symons; Christian Riehle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 3.  Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans?

Authors:  Joshua C Tremblay; Kyra E Pyke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

4.  Endothelial nitric oxide synthase activation is required for heparin receptor effects on vascular smooth muscle cells.

Authors:  Yaqiu Li; Leanna M Talotta-Altenburg; Kayli A Silimperi; Grace O Ciabattoni; Linda J Lowe-Krentz
Journal:  Am J Physiol Cell Physiol       Date:  2019-12-31       Impact factor: 4.249

5.  Evidence of sex differences in the acute impact of oscillatory shear stress on endothelial function.

Authors:  Joshua C Tremblay; Taylor V Stimpson; Kyra E Pyke
Journal:  J Appl Physiol (1985)       Date:  2018-11-01

6.  Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Authors:  H L Mooij; P Cabrales; S J Bernelot Moens; D Xu; S D Udayappan; A G Tsai; M A J van der Sande; E de Groot; M Intaglietta; J J P Kastelein; G M Dallinga-Thie; J D Esko; E S Stroes; M Nieuwdorp
Journal:  J Am Heart Assoc       Date:  2014-12-02       Impact factor: 5.501

7.  The Role of Nitric Oxide during Sonoreperfusion of Microvascular Obstruction.

Authors:  Francois T H Yu; Xucai Chen; Adam C Straub; John J Pacella
Journal:  Theranostics       Date:  2017-08-18       Impact factor: 11.556

8.  Pro-atherosclerotic disturbed flow disrupts caveolin-1 expression, localization, and function via glycocalyx degradation.

Authors:  Ian C Harding; Ronodeep Mitra; Solomon A Mensah; Ira M Herman; Eno E Ebong
Journal:  J Transl Med       Date:  2018-12-18       Impact factor: 5.531

9.  Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword.

Authors:  Guanghong Jia; James R Sowers
Journal:  Diabetes       Date:  2015-11       Impact factor: 9.461

10.  Flow does not alter eNOS phosphoryation at Ser1179 or Thr495 in preconstricted mouse mesenteric arteries.

Authors:  Robin C Looft-Wilson; Sarah E Todd; Kristen M Berberich; Madeline R Wolfert
Journal:  Physiol Rep       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.